SCHEDULE 13G//SEC Filing
SAB Biotherapeutics, Inc. SCHEDULE 13G
Accession 0001213900-25-096128
CIK 0001930214other
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 4:30 PM ET
Size
27.1 KB
Accession
0001213900-25-096128
Issuer
Vivo Opportunity Fund Holdings, L.P.
CIK 0001930214
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001930214
Filing Metadata
- Form type
- SCHEDULE 13G
- Filed
- Oct 2, 8:00 PM ET
- Accepted
- Oct 3, 4:30 PM ET
- Size
- 27.1 KB